Syed Saad Mahmood, MD, MPH, HF-Cert

About Syed Saad Mahmood, MD, MPH, HF-Cert

Dr Mahmood is a Cardio-Oncologist – i.e. a cardiac sub-specialist focused on preventing and treating cardiovascular toxicities of cancer therapies among active cancer patients and cancer survivors. His research focus is on cardiotoxicity of oncology immunotherapy such as immune checkpoint inhibitor associated myocarditis, and he is principal investigator of a multi-center chimeric antigen receptor T-cell therapy registry. He has published in Lancet, JAMA, and his work has been cited > 6,800 times.

Dr Mahmood is System Director of Cardio-Oncology at St Francis Heart Center and Catholic Health Services of Long Island which under his leadership was awarded ‘Center of Excellence’ designation with Gold (highest) status by the International Cardio-Oncology Society. He is course director of a monthly Cardio-Oncology journal club that is broadcast world-wide (OPCI.live/cardio-oncology). Previously, he was founder/Interim Director of Cardio-Oncology Program at Weill Cornell Medicine where he was Assistant Professor in Medicine; and has also been on faculty at Harvard Medical School, and Memorial Sloan Kettering Cancer Center. He completed internal medicine residency at Massachusetts General Hospital (MGH), Harvard Medical School, and his cardiovascular disease fellowship at Weill Cornell Medicine where he was chief fellow. He also completed a two-year Cardio-Oncology fellowship at Brigham and Women's Hospital (heart failure section) and MGH, Harvard Medical School. He is a graduate of Case Western medical school.

Education & Training

Doctoral Degree